nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP1B1—Tamoxifen—pancreatic cancer	0.0651	0.0814	CbGbCtD
Propofol—CYP1B1—Erlotinib—pancreatic cancer	0.0553	0.0692	CbGbCtD
Propofol—UGT1A9—Irinotecan—pancreatic cancer	0.0528	0.066	CbGbCtD
Propofol—UGT1A1—Erlotinib—pancreatic cancer	0.0478	0.0598	CbGbCtD
Propofol—UGT1A1—Irinotecan—pancreatic cancer	0.0432	0.054	CbGbCtD
Propofol—CYP1B1—Docetaxel—pancreatic cancer	0.0366	0.0458	CbGbCtD
Propofol—CYP1A1—Dacarbazine—pancreatic cancer	0.0359	0.0449	CbGbCtD
Propofol—CYP2A6—Tamoxifen—pancreatic cancer	0.0334	0.0418	CbGbCtD
Propofol—CYP1A1—Tamoxifen—pancreatic cancer	0.0286	0.0357	CbGbCtD
Propofol—CYP2E1—Dacarbazine—pancreatic cancer	0.0277	0.0347	CbGbCtD
Propofol—CYP1B1—Doxorubicin—pancreatic cancer	0.0273	0.0341	CbGbCtD
Propofol—CYP2A6—Fluorouracil—pancreatic cancer	0.0246	0.0308	CbGbCtD
Propofol—CYP1A1—Erlotinib—pancreatic cancer	0.0243	0.0304	CbGbCtD
Propofol—CYP2E1—Tamoxifen—pancreatic cancer	0.0221	0.0276	CbGbCtD
Propofol—CYP2B6—Tamoxifen—pancreatic cancer	0.0218	0.0272	CbGbCtD
Propofol—ALB—Erlotinib—pancreatic cancer	0.0181	0.0227	CbGbCtD
Propofol—CYP2B6—Irinotecan—pancreatic cancer	0.0167	0.0209	CbGbCtD
Propofol—CYP2C8—Tamoxifen—pancreatic cancer	0.0165	0.0206	CbGbCtD
Propofol—ALB—Irinotecan—pancreatic cancer	0.0164	0.0205	CbGbCtD
Propofol—CYP1A2—Dacarbazine—pancreatic cancer	0.016	0.02	CbGbCtD
Propofol—ALB—Fluorouracil—pancreatic cancer	0.0157	0.0196	CbGbCtD
Propofol—CYP2C8—Erlotinib—pancreatic cancer	0.014	0.0175	CbGbCtD
Propofol—CYP2C19—Tamoxifen—pancreatic cancer	0.0138	0.0173	CbGbCtD
Propofol—CYP1A2—Tamoxifen—pancreatic cancer	0.0128	0.0159	CbGbCtD
Propofol—CYP2C8—Fluorouracil—pancreatic cancer	0.0121	0.0152	CbGbCtD
Propofol—CYP2C9—Tamoxifen—pancreatic cancer	0.0115	0.0144	CbGbCtD
Propofol—CYP1A2—Erlotinib—pancreatic cancer	0.0108	0.0136	CbGbCtD
Propofol—CYP2D6—Tamoxifen—pancreatic cancer	0.0105	0.0131	CbGbCtD
Propofol—CYP1A2—Fluorouracil—pancreatic cancer	0.0094	0.0118	CbGbCtD
Propofol—CYP2B6—Doxorubicin—pancreatic cancer	0.00913	0.0114	CbGbCtD
Propofol—CYP2D6—Erlotinib—pancreatic cancer	0.00894	0.0112	CbGbCtD
Propofol—CYP2C9—Fluorouracil—pancreatic cancer	0.00847	0.0106	CbGbCtD
Propofol—CYP3A4—Tamoxifen—pancreatic cancer	0.00669	0.00836	CbGbCtD
Propofol—CYP3A4—Erlotinib—pancreatic cancer	0.00568	0.00711	CbGbCtD
Propofol—CYP3A4—Irinotecan—pancreatic cancer	0.00513	0.00642	CbGbCtD
Propofol—CYP2D6—Doxorubicin—pancreatic cancer	0.00441	0.00551	CbGbCtD
Propofol—CYP3A4—Docetaxel—pancreatic cancer	0.00376	0.0047	CbGbCtD
Propofol—CYP3A4—Sunitinib—pancreatic cancer	0.00374	0.00468	CbGbCtD
Propofol—CYP3A4—Doxorubicin—pancreatic cancer	0.0028	0.00351	CbGbCtD
Propofol—Eye pain—Doxorubicin—pancreatic cancer	0.000204	0.00124	CcSEcCtD
Propofol—Cardiac failure—Epirubicin—pancreatic cancer	0.000204	0.00124	CcSEcCtD
Propofol—Diarrhoea—Tamoxifen—pancreatic cancer	0.000203	0.00123	CcSEcCtD
Propofol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000203	0.00123	CcSEcCtD
Propofol—Confusional state—Fluorouracil—pancreatic cancer	0.000202	0.00123	CcSEcCtD
Propofol—Pharyngitis—Docetaxel—pancreatic cancer	0.000202	0.00123	CcSEcCtD
Propofol—Abdominal pain—Sunitinib—pancreatic cancer	0.000201	0.00122	CcSEcCtD
Propofol—Body temperature increased—Sunitinib—pancreatic cancer	0.000201	0.00122	CcSEcCtD
Propofol—Diarrhoea—Erlotinib—pancreatic cancer	0.000201	0.00122	CcSEcCtD
Propofol—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000201	0.00122	CcSEcCtD
Propofol—Oedema—Fluorouracil—pancreatic cancer	0.000201	0.00122	CcSEcCtD
Propofol—Diplopia—Epirubicin—pancreatic cancer	0.000199	0.00121	CcSEcCtD
Propofol—Pain in extremity—Epirubicin—pancreatic cancer	0.000199	0.00121	CcSEcCtD
Propofol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000197	0.0012	CcSEcCtD
Propofol—Visual impairment—Docetaxel—pancreatic cancer	0.000197	0.00119	CcSEcCtD
Propofol—Dizziness—Tamoxifen—pancreatic cancer	0.000196	0.00119	CcSEcCtD
Propofol—Tachycardia—Fluorouracil—pancreatic cancer	0.000196	0.00119	CcSEcCtD
Propofol—Hypotension—Irinotecan—pancreatic cancer	0.000196	0.00119	CcSEcCtD
Propofol—Affect lability—Epirubicin—pancreatic cancer	0.000196	0.00119	CcSEcCtD
Propofol—Dizziness—Erlotinib—pancreatic cancer	0.000194	0.00118	CcSEcCtD
Propofol—Hypotension—Gemcitabine—pancreatic cancer	0.000191	0.00116	CcSEcCtD
Propofol—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00019	0.00115	CcSEcCtD
Propofol—Insomnia—Irinotecan—pancreatic cancer	0.00019	0.00115	CcSEcCtD
Propofol—Flushing—Docetaxel—pancreatic cancer	0.000189	0.00115	CcSEcCtD
Propofol—Cardiac arrest—Epirubicin—pancreatic cancer	0.000189	0.00115	CcSEcCtD
Propofol—Vomiting—Tamoxifen—pancreatic cancer	0.000189	0.00115	CcSEcCtD
Propofol—Cardiac failure—Doxorubicin—pancreatic cancer	0.000189	0.00114	CcSEcCtD
Propofol—Mood swings—Epirubicin—pancreatic cancer	0.000188	0.00114	CcSEcCtD
Propofol—Paraesthesia—Irinotecan—pancreatic cancer	0.000188	0.00114	CcSEcCtD
Propofol—Hypotension—Fluorouracil—pancreatic cancer	0.000188	0.00114	CcSEcCtD
Propofol—Rash—Tamoxifen—pancreatic cancer	0.000187	0.00114	CcSEcCtD
Propofol—Dermatitis—Tamoxifen—pancreatic cancer	0.000187	0.00114	CcSEcCtD
Propofol—Vomiting—Erlotinib—pancreatic cancer	0.000187	0.00113	CcSEcCtD
Propofol—Dyspnoea—Irinotecan—pancreatic cancer	0.000187	0.00113	CcSEcCtD
Propofol—Somnolence—Irinotecan—pancreatic cancer	0.000186	0.00113	CcSEcCtD
Propofol—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000186	0.00113	CcSEcCtD
Propofol—Headache—Tamoxifen—pancreatic cancer	0.000186	0.00113	CcSEcCtD
Propofol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000186	0.00113	CcSEcCtD
Propofol—Rash—Erlotinib—pancreatic cancer	0.000185	0.00112	CcSEcCtD
Propofol—Dermatitis—Erlotinib—pancreatic cancer	0.000185	0.00112	CcSEcCtD
Propofol—Dehydration—Epirubicin—pancreatic cancer	0.000185	0.00112	CcSEcCtD
Propofol—Insomnia—Gemcitabine—pancreatic cancer	0.000185	0.00112	CcSEcCtD
Propofol—Headache—Erlotinib—pancreatic cancer	0.000184	0.00112	CcSEcCtD
Propofol—Diplopia—Doxorubicin—pancreatic cancer	0.000184	0.00112	CcSEcCtD
Propofol—Pain in extremity—Doxorubicin—pancreatic cancer	0.000184	0.00112	CcSEcCtD
Propofol—Paraesthesia—Gemcitabine—pancreatic cancer	0.000183	0.00111	CcSEcCtD
Propofol—Chills—Docetaxel—pancreatic cancer	0.000183	0.00111	CcSEcCtD
Propofol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000183	0.00111	CcSEcCtD
Propofol—Asthenia—Sunitinib—pancreatic cancer	0.000183	0.00111	CcSEcCtD
Propofol—Arrhythmia—Docetaxel—pancreatic cancer	0.000182	0.00111	CcSEcCtD
Propofol—Dyspnoea—Gemcitabine—pancreatic cancer	0.000182	0.0011	CcSEcCtD
Propofol—Insomnia—Fluorouracil—pancreatic cancer	0.000182	0.0011	CcSEcCtD
Propofol—Somnolence—Gemcitabine—pancreatic cancer	0.000182	0.0011	CcSEcCtD
Propofol—Affect lability—Doxorubicin—pancreatic cancer	0.000181	0.0011	CcSEcCtD
Propofol—Fatigue—Irinotecan—pancreatic cancer	0.000181	0.0011	CcSEcCtD
Propofol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00018	0.00109	CcSEcCtD
Propofol—Pruritus—Sunitinib—pancreatic cancer	0.00018	0.00109	CcSEcCtD
Propofol—Pain—Irinotecan—pancreatic cancer	0.000179	0.00109	CcSEcCtD
Propofol—Dyspnoea—Fluorouracil—pancreatic cancer	0.000179	0.00109	CcSEcCtD
Propofol—Somnolence—Fluorouracil—pancreatic cancer	0.000178	0.00108	CcSEcCtD
Propofol—Erythema—Docetaxel—pancreatic cancer	0.000178	0.00108	CcSEcCtD
Propofol—Nausea—Tamoxifen—pancreatic cancer	0.000176	0.00107	CcSEcCtD
Propofol—Fatigue—Gemcitabine—pancreatic cancer	0.000176	0.00107	CcSEcCtD
Propofol—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000175	0.00106	CcSEcCtD
Propofol—Pain—Gemcitabine—pancreatic cancer	0.000175	0.00106	CcSEcCtD
Propofol—Nausea—Erlotinib—pancreatic cancer	0.000175	0.00106	CcSEcCtD
Propofol—Mood swings—Doxorubicin—pancreatic cancer	0.000174	0.00106	CcSEcCtD
Propofol—Diarrhoea—Sunitinib—pancreatic cancer	0.000174	0.00106	CcSEcCtD
Propofol—Dysgeusia—Docetaxel—pancreatic cancer	0.000174	0.00105	CcSEcCtD
Propofol—Feeling abnormal—Irinotecan—pancreatic cancer	0.000173	0.00105	CcSEcCtD
Propofol—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000172	0.00105	CcSEcCtD
Propofol—Pain—Fluorouracil—pancreatic cancer	0.000172	0.00104	CcSEcCtD
Propofol—Dehydration—Doxorubicin—pancreatic cancer	0.000171	0.00104	CcSEcCtD
Propofol—Muscle spasms—Docetaxel—pancreatic cancer	0.000171	0.00104	CcSEcCtD
Propofol—Pancreatitis—Epirubicin—pancreatic cancer	0.000169	0.00102	CcSEcCtD
Propofol—Dizziness—Sunitinib—pancreatic cancer	0.000168	0.00102	CcSEcCtD
Propofol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000168	0.00102	CcSEcCtD
Propofol—Abdominal pain—Irinotecan—pancreatic cancer	0.000166	0.00101	CcSEcCtD
Propofol—Body temperature increased—Irinotecan—pancreatic cancer	0.000166	0.00101	CcSEcCtD
Propofol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000165	0.001	CcSEcCtD
Propofol—Vomiting—Sunitinib—pancreatic cancer	0.000162	0.000981	CcSEcCtD
Propofol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000161	0.000979	CcSEcCtD
Propofol—Rash—Sunitinib—pancreatic cancer	0.00016	0.000973	CcSEcCtD
Propofol—Dermatitis—Sunitinib—pancreatic cancer	0.00016	0.000972	CcSEcCtD
Propofol—Urticaria—Fluorouracil—pancreatic cancer	0.000159	0.000967	CcSEcCtD
Propofol—Headache—Sunitinib—pancreatic cancer	0.000159	0.000967	CcSEcCtD
Propofol—Syncope—Docetaxel—pancreatic cancer	0.000159	0.000966	CcSEcCtD
Propofol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000159	0.000963	CcSEcCtD
Propofol—Loss of consciousness—Docetaxel—pancreatic cancer	0.000156	0.000947	CcSEcCtD
Propofol—Pancreatitis—Doxorubicin—pancreatic cancer	0.000156	0.000946	CcSEcCtD
Propofol—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000155	0.00094	CcSEcCtD
Propofol—Cough—Docetaxel—pancreatic cancer	0.000155	0.00094	CcSEcCtD
Propofol—Convulsion—Docetaxel—pancreatic cancer	0.000154	0.000933	CcSEcCtD
Propofol—Hypertension—Docetaxel—pancreatic cancer	0.000153	0.00093	CcSEcCtD
Propofol—Chest pain—Docetaxel—pancreatic cancer	0.000151	0.000917	CcSEcCtD
Propofol—Myalgia—Docetaxel—pancreatic cancer	0.000151	0.000917	CcSEcCtD
Propofol—Nausea—Sunitinib—pancreatic cancer	0.000151	0.000917	CcSEcCtD
Propofol—Renal failure—Epirubicin—pancreatic cancer	0.000151	0.000914	CcSEcCtD
Propofol—Asthenia—Irinotecan—pancreatic cancer	0.00015	0.000912	CcSEcCtD
Propofol—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00015	0.000911	CcSEcCtD
Propofol—Dry mouth—Docetaxel—pancreatic cancer	0.000148	0.000897	CcSEcCtD
Propofol—Asthenia—Gemcitabine—pancreatic cancer	0.000147	0.000889	CcSEcCtD
Propofol—Confusional state—Docetaxel—pancreatic cancer	0.000146	0.000886	CcSEcCtD
Propofol—Oedema—Docetaxel—pancreatic cancer	0.000145	0.000879	CcSEcCtD
Propofol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000145	0.000879	CcSEcCtD
Propofol—Pruritus—Gemcitabine—pancreatic cancer	0.000144	0.000876	CcSEcCtD
Propofol—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000143	0.00087	CcSEcCtD
Propofol—Diarrhoea—Irinotecan—pancreatic cancer	0.000143	0.00087	CcSEcCtD
Propofol—Shock—Docetaxel—pancreatic cancer	0.000143	0.000865	CcSEcCtD
Propofol—Pruritus—Fluorouracil—pancreatic cancer	0.000142	0.000862	CcSEcCtD
Propofol—Tachycardia—Docetaxel—pancreatic cancer	0.000141	0.000858	CcSEcCtD
Propofol—Bradycardia—Epirubicin—pancreatic cancer	0.00014	0.000849	CcSEcCtD
Propofol—Diarrhoea—Gemcitabine—pancreatic cancer	0.00014	0.000847	CcSEcCtD
Propofol—Renal failure—Doxorubicin—pancreatic cancer	0.000139	0.000845	CcSEcCtD
Propofol—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000139	0.000843	CcSEcCtD
Propofol—Dizziness—Irinotecan—pancreatic cancer	0.000139	0.000841	CcSEcCtD
Propofol—Haemoglobin—Epirubicin—pancreatic cancer	0.000138	0.000839	CcSEcCtD
Propofol—Haemorrhage—Epirubicin—pancreatic cancer	0.000138	0.000834	CcSEcCtD
Propofol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000137	0.000833	CcSEcCtD
Propofol—Pharyngitis—Epirubicin—pancreatic cancer	0.000137	0.000828	CcSEcCtD
Propofol—Hypotension—Docetaxel—pancreatic cancer	0.000135	0.000821	CcSEcCtD
Propofol—Vomiting—Irinotecan—pancreatic cancer	0.000133	0.000808	CcSEcCtD
Propofol—Dizziness—Fluorouracil—pancreatic cancer	0.000133	0.000805	CcSEcCtD
Propofol—Visual impairment—Epirubicin—pancreatic cancer	0.000133	0.000804	CcSEcCtD
Propofol—Rash—Irinotecan—pancreatic cancer	0.000132	0.000802	CcSEcCtD
Propofol—Dermatitis—Irinotecan—pancreatic cancer	0.000132	0.000801	CcSEcCtD
Propofol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000132	0.000801	CcSEcCtD
Propofol—Headache—Irinotecan—pancreatic cancer	0.000131	0.000797	CcSEcCtD
Propofol—Insomnia—Docetaxel—pancreatic cancer	0.000131	0.000795	CcSEcCtD
Propofol—Paraesthesia—Docetaxel—pancreatic cancer	0.00013	0.000789	CcSEcCtD
Propofol—Vomiting—Gemcitabine—pancreatic cancer	0.00013	0.000787	CcSEcCtD
Propofol—Bradycardia—Doxorubicin—pancreatic cancer	0.00013	0.000786	CcSEcCtD
Propofol—Dyspnoea—Docetaxel—pancreatic cancer	0.000129	0.000784	CcSEcCtD
Propofol—Somnolence—Docetaxel—pancreatic cancer	0.000129	0.000781	CcSEcCtD
Propofol—Rash—Gemcitabine—pancreatic cancer	0.000129	0.000781	CcSEcCtD
Propofol—Dermatitis—Gemcitabine—pancreatic cancer	0.000129	0.00078	CcSEcCtD
Propofol—Tinnitus—Epirubicin—pancreatic cancer	0.000128	0.000778	CcSEcCtD
Propofol—Haemoglobin—Doxorubicin—pancreatic cancer	0.000128	0.000776	CcSEcCtD
Propofol—Headache—Gemcitabine—pancreatic cancer	0.000128	0.000776	CcSEcCtD
Propofol—Flushing—Epirubicin—pancreatic cancer	0.000128	0.000774	CcSEcCtD
Propofol—Vomiting—Fluorouracil—pancreatic cancer	0.000128	0.000774	CcSEcCtD
Propofol—Haemorrhage—Doxorubicin—pancreatic cancer	0.000127	0.000772	CcSEcCtD
Propofol—Rash—Fluorouracil—pancreatic cancer	0.000127	0.000768	CcSEcCtD
Propofol—Dermatitis—Fluorouracil—pancreatic cancer	0.000126	0.000767	CcSEcCtD
Propofol—Pharyngitis—Doxorubicin—pancreatic cancer	0.000126	0.000766	CcSEcCtD
Propofol—Headache—Fluorouracil—pancreatic cancer	0.000126	0.000763	CcSEcCtD
Propofol—Fatigue—Docetaxel—pancreatic cancer	0.000125	0.000758	CcSEcCtD
Propofol—Nausea—Irinotecan—pancreatic cancer	0.000125	0.000755	CcSEcCtD
Propofol—Pain—Docetaxel—pancreatic cancer	0.000124	0.000752	CcSEcCtD
Propofol—Chills—Epirubicin—pancreatic cancer	0.000123	0.000749	CcSEcCtD
Propofol—Arrhythmia—Epirubicin—pancreatic cancer	0.000123	0.000745	CcSEcCtD
Propofol—Visual impairment—Doxorubicin—pancreatic cancer	0.000123	0.000744	CcSEcCtD
Propofol—Nausea—Gemcitabine—pancreatic cancer	0.000121	0.000736	CcSEcCtD
Propofol—Erythema—Epirubicin—pancreatic cancer	0.00012	0.000726	CcSEcCtD
Propofol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000119	0.000724	CcSEcCtD
Propofol—Nausea—Fluorouracil—pancreatic cancer	0.000119	0.000723	CcSEcCtD
Propofol—Tinnitus—Doxorubicin—pancreatic cancer	0.000119	0.00072	CcSEcCtD
Propofol—Flushing—Doxorubicin—pancreatic cancer	0.000118	0.000717	CcSEcCtD
Propofol—Dysgeusia—Epirubicin—pancreatic cancer	0.000117	0.000711	CcSEcCtD
Propofol—Muscle spasms—Epirubicin—pancreatic cancer	0.000115	0.000698	CcSEcCtD
Propofol—Body temperature increased—Docetaxel—pancreatic cancer	0.000115	0.000695	CcSEcCtD
Propofol—Abdominal pain—Docetaxel—pancreatic cancer	0.000115	0.000695	CcSEcCtD
Propofol—Chills—Doxorubicin—pancreatic cancer	0.000114	0.000693	CcSEcCtD
Propofol—Arrhythmia—Doxorubicin—pancreatic cancer	0.000114	0.00069	CcSEcCtD
Propofol—Erythema—Doxorubicin—pancreatic cancer	0.000111	0.000672	CcSEcCtD
Propofol—Agitation—Epirubicin—pancreatic cancer	0.00011	0.000668	CcSEcCtD
Propofol—Dysgeusia—Doxorubicin—pancreatic cancer	0.000109	0.000658	CcSEcCtD
Propofol—Syncope—Epirubicin—pancreatic cancer	0.000107	0.000651	CcSEcCtD
Propofol—Muscle spasms—Doxorubicin—pancreatic cancer	0.000107	0.000646	CcSEcCtD
Propofol—Loss of consciousness—Epirubicin—pancreatic cancer	0.000105	0.000638	CcSEcCtD
Propofol—Cough—Epirubicin—pancreatic cancer	0.000105	0.000634	CcSEcCtD
Propofol—Asthenia—Docetaxel—pancreatic cancer	0.000104	0.000631	CcSEcCtD
Propofol—Convulsion—Epirubicin—pancreatic cancer	0.000104	0.000629	CcSEcCtD
Propofol—Hypertension—Epirubicin—pancreatic cancer	0.000103	0.000627	CcSEcCtD
Propofol—Pruritus—Docetaxel—pancreatic cancer	0.000103	0.000622	CcSEcCtD
Propofol—Myalgia—Epirubicin—pancreatic cancer	0.000102	0.000618	CcSEcCtD
Propofol—Chest pain—Epirubicin—pancreatic cancer	0.000102	0.000618	CcSEcCtD
Propofol—Agitation—Doxorubicin—pancreatic cancer	0.000102	0.000618	CcSEcCtD
Propofol—Anxiety—Epirubicin—pancreatic cancer	0.000102	0.000616	CcSEcCtD
Propofol—Dry mouth—Epirubicin—pancreatic cancer	9.97e-05	0.000605	CcSEcCtD
Propofol—Syncope—Doxorubicin—pancreatic cancer	9.94e-05	0.000603	CcSEcCtD
Propofol—Diarrhoea—Docetaxel—pancreatic cancer	9.92e-05	0.000601	CcSEcCtD
Propofol—Confusional state—Epirubicin—pancreatic cancer	9.86e-05	0.000598	CcSEcCtD
Propofol—Oedema—Epirubicin—pancreatic cancer	9.77e-05	0.000593	CcSEcCtD
Propofol—Anaphylactic shock—Epirubicin—pancreatic cancer	9.77e-05	0.000593	CcSEcCtD
Propofol—Loss of consciousness—Doxorubicin—pancreatic cancer	9.74e-05	0.000591	CcSEcCtD
Propofol—Cough—Doxorubicin—pancreatic cancer	9.67e-05	0.000586	CcSEcCtD
Propofol—Shock—Epirubicin—pancreatic cancer	9.62e-05	0.000583	CcSEcCtD
Propofol—Convulsion—Doxorubicin—pancreatic cancer	9.6e-05	0.000582	CcSEcCtD
Propofol—Dizziness—Docetaxel—pancreatic cancer	9.58e-05	0.000581	CcSEcCtD
Propofol—Hypertension—Doxorubicin—pancreatic cancer	9.57e-05	0.00058	CcSEcCtD
Propofol—Tachycardia—Epirubicin—pancreatic cancer	9.54e-05	0.000579	CcSEcCtD
Propofol—Hyperhidrosis—Epirubicin—pancreatic cancer	9.45e-05	0.000573	CcSEcCtD
Propofol—Myalgia—Doxorubicin—pancreatic cancer	9.43e-05	0.000572	CcSEcCtD
Propofol—Chest pain—Doxorubicin—pancreatic cancer	9.43e-05	0.000572	CcSEcCtD
Propofol—Anxiety—Doxorubicin—pancreatic cancer	9.4e-05	0.00057	CcSEcCtD
Propofol—Dry mouth—Doxorubicin—pancreatic cancer	9.23e-05	0.00056	CcSEcCtD
Propofol—Vomiting—Docetaxel—pancreatic cancer	9.21e-05	0.000559	CcSEcCtD
Propofol—Rash—Docetaxel—pancreatic cancer	9.14e-05	0.000554	CcSEcCtD
Propofol—Hypotension—Epirubicin—pancreatic cancer	9.13e-05	0.000554	CcSEcCtD
Propofol—Dermatitis—Docetaxel—pancreatic cancer	9.13e-05	0.000554	CcSEcCtD
Propofol—Confusional state—Doxorubicin—pancreatic cancer	9.12e-05	0.000553	CcSEcCtD
Propofol—Headache—Docetaxel—pancreatic cancer	9.08e-05	0.000551	CcSEcCtD
Propofol—Oedema—Doxorubicin—pancreatic cancer	9.04e-05	0.000549	CcSEcCtD
Propofol—Anaphylactic shock—Doxorubicin—pancreatic cancer	9.04e-05	0.000549	CcSEcCtD
Propofol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.91e-05	0.00054	CcSEcCtD
Propofol—Shock—Doxorubicin—pancreatic cancer	8.9e-05	0.00054	CcSEcCtD
Propofol—Insomnia—Epirubicin—pancreatic cancer	8.84e-05	0.000536	CcSEcCtD
Propofol—Tachycardia—Doxorubicin—pancreatic cancer	8.83e-05	0.000535	CcSEcCtD
Propofol—Paraesthesia—Epirubicin—pancreatic cancer	8.78e-05	0.000532	CcSEcCtD
Propofol—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.74e-05	0.00053	CcSEcCtD
Propofol—Dyspnoea—Epirubicin—pancreatic cancer	8.71e-05	0.000529	CcSEcCtD
Propofol—Somnolence—Epirubicin—pancreatic cancer	8.69e-05	0.000527	CcSEcCtD
Propofol—Nausea—Docetaxel—pancreatic cancer	8.61e-05	0.000522	CcSEcCtD
Propofol—Hypotension—Doxorubicin—pancreatic cancer	8.45e-05	0.000513	CcSEcCtD
Propofol—Fatigue—Epirubicin—pancreatic cancer	8.43e-05	0.000511	CcSEcCtD
Propofol—Pain—Epirubicin—pancreatic cancer	8.36e-05	0.000507	CcSEcCtD
Propofol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.24e-05	0.0005	CcSEcCtD
Propofol—Insomnia—Doxorubicin—pancreatic cancer	8.18e-05	0.000496	CcSEcCtD
Propofol—Paraesthesia—Doxorubicin—pancreatic cancer	8.12e-05	0.000493	CcSEcCtD
Propofol—Dyspnoea—Doxorubicin—pancreatic cancer	8.06e-05	0.000489	CcSEcCtD
Propofol—Feeling abnormal—Epirubicin—pancreatic cancer	8.05e-05	0.000489	CcSEcCtD
Propofol—Somnolence—Doxorubicin—pancreatic cancer	8.04e-05	0.000488	CcSEcCtD
Propofol—Fatigue—Doxorubicin—pancreatic cancer	7.8e-05	0.000473	CcSEcCtD
Propofol—Urticaria—Epirubicin—pancreatic cancer	7.76e-05	0.000471	CcSEcCtD
Propofol—Pain—Doxorubicin—pancreatic cancer	7.73e-05	0.000469	CcSEcCtD
Propofol—Body temperature increased—Epirubicin—pancreatic cancer	7.73e-05	0.000469	CcSEcCtD
Propofol—Abdominal pain—Epirubicin—pancreatic cancer	7.73e-05	0.000469	CcSEcCtD
Propofol—Feeling abnormal—Doxorubicin—pancreatic cancer	7.45e-05	0.000452	CcSEcCtD
Propofol—Urticaria—Doxorubicin—pancreatic cancer	7.18e-05	0.000436	CcSEcCtD
Propofol—Abdominal pain—Doxorubicin—pancreatic cancer	7.15e-05	0.000434	CcSEcCtD
Propofol—Body temperature increased—Doxorubicin—pancreatic cancer	7.15e-05	0.000434	CcSEcCtD
Propofol—Asthenia—Epirubicin—pancreatic cancer	7.01e-05	0.000425	CcSEcCtD
Propofol—Pruritus—Epirubicin—pancreatic cancer	6.92e-05	0.000419	CcSEcCtD
Propofol—Diarrhoea—Epirubicin—pancreatic cancer	6.69e-05	0.000406	CcSEcCtD
Propofol—Asthenia—Doxorubicin—pancreatic cancer	6.49e-05	0.000394	CcSEcCtD
Propofol—Dizziness—Epirubicin—pancreatic cancer	6.46e-05	0.000392	CcSEcCtD
Propofol—Pruritus—Doxorubicin—pancreatic cancer	6.4e-05	0.000388	CcSEcCtD
Propofol—Vomiting—Epirubicin—pancreatic cancer	6.21e-05	0.000377	CcSEcCtD
Propofol—Diarrhoea—Doxorubicin—pancreatic cancer	6.19e-05	0.000375	CcSEcCtD
Propofol—Rash—Epirubicin—pancreatic cancer	6.16e-05	0.000374	CcSEcCtD
Propofol—Dermatitis—Epirubicin—pancreatic cancer	6.16e-05	0.000373	CcSEcCtD
Propofol—Headache—Epirubicin—pancreatic cancer	6.12e-05	0.000371	CcSEcCtD
Propofol—Dizziness—Doxorubicin—pancreatic cancer	5.98e-05	0.000363	CcSEcCtD
Propofol—Nausea—Epirubicin—pancreatic cancer	5.81e-05	0.000352	CcSEcCtD
Propofol—Vomiting—Doxorubicin—pancreatic cancer	5.75e-05	0.000349	CcSEcCtD
Propofol—Rash—Doxorubicin—pancreatic cancer	5.7e-05	0.000346	CcSEcCtD
Propofol—Dermatitis—Doxorubicin—pancreatic cancer	5.7e-05	0.000346	CcSEcCtD
Propofol—Headache—Doxorubicin—pancreatic cancer	5.67e-05	0.000344	CcSEcCtD
Propofol—Nausea—Doxorubicin—pancreatic cancer	5.37e-05	0.000326	CcSEcCtD
Propofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	8.18e-06	0.000233	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.18e-06	0.000233	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GLP1R—pancreatic cancer	7.99e-06	0.000227	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.98e-06	0.000227	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CD—pancreatic cancer	7.94e-06	0.000226	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.93e-06	0.000226	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.93e-06	0.000226	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PRSS1—pancreatic cancer	7.86e-06	0.000224	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—DPYD—pancreatic cancer	7.86e-06	0.000224	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CD—pancreatic cancer	7.78e-06	0.000221	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—APOE—pancreatic cancer	7.75e-06	0.000221	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—APOE—pancreatic cancer	7.75e-06	0.000221	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—TYMP—pancreatic cancer	7.72e-06	0.00022	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CD44—pancreatic cancer	7.64e-06	0.000218	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CD44—pancreatic cancer	7.48e-06	0.000213	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	7.46e-06	0.000212	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.46e-06	0.000212	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.38e-06	0.00021	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PIK3CA—pancreatic cancer	7.37e-06	0.00021	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	7.35e-06	0.000209	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—TYMS—pancreatic cancer	7.34e-06	0.000209	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.33e-06	0.000209	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GCG—pancreatic cancer	7.33e-06	0.000209	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GLP1R—pancreatic cancer	7.28e-06	0.000207	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.27e-06	0.000207	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—DPYD—pancreatic cancer	7.23e-06	0.000206	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.23e-06	0.000206	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—APOE—pancreatic cancer	7.23e-06	0.000206	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GCG—pancreatic cancer	7.18e-06	0.000204	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—DPYD—pancreatic cancer	7.16e-06	0.000204	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.12e-06	0.000203	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CD44—pancreatic cancer	7.06e-06	0.000201	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CG—pancreatic cancer	6.99e-06	0.000199	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	6.99e-06	0.000199	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CB—pancreatic cancer	6.92e-06	0.000197	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.91e-06	0.000197	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—STK11—pancreatic cancer	6.89e-06	0.000196	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	6.86e-06	0.000195	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.85e-06	0.000195	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.84e-06	0.000195	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ARG2—pancreatic cancer	6.82e-06	0.000194	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	6.8e-06	0.000194	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CB—pancreatic cancer	6.78e-06	0.000193	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GCG—pancreatic cancer	6.77e-06	0.000193	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PPARG—pancreatic cancer	6.75e-06	0.000192	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PPARG—pancreatic cancer	6.75e-06	0.000192	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—STK11—pancreatic cancer	6.75e-06	0.000192	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.73e-06	0.000192	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTGS2—pancreatic cancer	6.72e-06	0.000191	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	6.68e-06	0.00019	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	6.52e-06	0.000186	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.49e-06	0.000185	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.49e-06	0.000185	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CD44—pancreatic cancer	6.47e-06	0.000184	CbGpPWpGaD
Propofol—ALB—Metabolism—CD44—pancreatic cancer	6.43e-06	0.000183	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.37e-06	0.000181	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—STK11—pancreatic cancer	6.36e-06	0.000181	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.33e-06	0.00018	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.3e-06	0.000179	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PPARG—pancreatic cancer	6.29e-06	0.000179	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.28e-06	0.000179	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.24e-06	0.000178	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GLP1R—pancreatic cancer	6.22e-06	0.000177	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GCG—pancreatic cancer	6.2e-06	0.000177	CbGpPWpGaD
Propofol—ALB—Metabolism—GCG—pancreatic cancer	6.17e-06	0.000176	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	6.15e-06	0.000175	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	6.15e-06	0.000175	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—DPYD—pancreatic cancer	6.12e-06	0.000174	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AKT1—pancreatic cancer	6.02e-06	0.000171	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—APOE—pancreatic cancer	5.97e-06	0.00017	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.97e-06	0.00017	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—TYMP—pancreatic cancer	5.96e-06	0.00017	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—TYMS—pancreatic cancer	5.93e-06	0.000169	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.92e-06	0.000168	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTEN—pancreatic cancer	5.86e-06	0.000167	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—STK11—pancreatic cancer	5.83e-06	0.000166	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	5.81e-06	0.000165	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—TYMS—pancreatic cancer	5.8e-06	0.000165	CbGpPWpGaD
Propofol—ALB—Metabolism—STK11—pancreatic cancer	5.8e-06	0.000165	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CD44—pancreatic cancer	5.77e-06	0.000164	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.75e-06	0.000164	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	5.73e-06	0.000163	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.65e-06	0.000161	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.6e-06	0.00016	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.55e-06	0.000158	CbGpPWpGaD
Propofol—ALB—Hemostasis—SRC—pancreatic cancer	5.54e-06	0.000158	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GCG—pancreatic cancer	5.54e-06	0.000158	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.47e-06	0.000156	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—TYMS—pancreatic cancer	5.47e-06	0.000156	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.44e-06	0.000155	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—pancreatic cancer	5.4e-06	0.000154	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	5.39e-06	0.000153	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	5.36e-06	0.000153	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	5.36e-06	0.000153	CbGpPWpGaD
Propofol—ALB—Hemostasis—NRAS—pancreatic cancer	5.33e-06	0.000152	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CD44—pancreatic cancer	5.31e-06	0.000151	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTGS2—pancreatic cancer	5.31e-06	0.000151	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTGS2—pancreatic cancer	5.31e-06	0.000151	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CD44—pancreatic cancer	5.27e-06	0.00015	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—STK11—pancreatic cancer	5.21e-06	0.000148	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PPARG—pancreatic cancer	5.2e-06	0.000148	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.16e-06	0.000147	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.11e-06	0.000145	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GCG—pancreatic cancer	5.09e-06	0.000145	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.05e-06	0.000144	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GCG—pancreatic cancer	5.05e-06	0.000144	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—TYMS—pancreatic cancer	5.02e-06	0.000143	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	5e-06	0.000142	CbGpPWpGaD
Propofol—ALB—Metabolism—TYMS—pancreatic cancer	4.99e-06	0.000142	CbGpPWpGaD
Propofol—ALB—Hemostasis—TGFB1—pancreatic cancer	4.96e-06	0.000141	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTGS2—pancreatic cancer	4.95e-06	0.000141	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.89e-06	0.000139	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—APOE—pancreatic cancer	4.82e-06	0.000137	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.8e-06	0.000137	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—STK11—pancreatic cancer	4.79e-06	0.000136	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—STK11—pancreatic cancer	4.75e-06	0.000135	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	4.74e-06	0.000135	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.73e-06	0.000135	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—APOE—pancreatic cancer	4.72e-06	0.000134	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTEN—pancreatic cancer	4.63e-06	0.000132	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTEN—pancreatic cancer	4.63e-06	0.000132	CbGpPWpGaD
Propofol—ALB—Hemostasis—KRAS—pancreatic cancer	4.59e-06	0.000131	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CD44—pancreatic cancer	4.5e-06	0.000128	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.48e-06	0.000128	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—TYMS—pancreatic cancer	4.48e-06	0.000127	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.46e-06	0.000127	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—APOE—pancreatic cancer	4.45e-06	0.000127	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.41e-06	0.000125	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.37e-06	0.000124	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	4.35e-06	0.000124	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTEN—pancreatic cancer	4.32e-06	0.000123	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GCG—pancreatic cancer	4.31e-06	0.000123	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	4.26e-06	0.000121	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CA—pancreatic cancer	4.22e-06	0.00012	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.21e-06	0.00012	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PPARG—pancreatic cancer	4.2e-06	0.00012	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CA—pancreatic cancer	4.13e-06	0.000118	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	4.13e-06	0.000118	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.12e-06	0.000117	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PPARG—pancreatic cancer	4.11e-06	0.000117	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTGS2—pancreatic cancer	4.09e-06	0.000117	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—TYMS—pancreatic cancer	4.08e-06	0.000116	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—pancreatic cancer	4.08e-06	0.000116	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—APOE—pancreatic cancer	4.08e-06	0.000116	CbGpPWpGaD
Propofol—ALB—Metabolism—APOE—pancreatic cancer	4.06e-06	0.000115	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—STK11—pancreatic cancer	4.06e-06	0.000115	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	4.02e-06	0.000114	CbGpPWpGaD
Propofol—ALB—Hemostasis—HRAS—pancreatic cancer	3.9e-06	0.000111	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PPARG—pancreatic cancer	3.88e-06	0.00011	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.86e-06	0.00011	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.84e-06	0.000109	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	3.82e-06	0.000109	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.81e-06	0.000108	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	3.74e-06	0.000107	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	3.68e-06	0.000105	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CG—pancreatic cancer	3.66e-06	0.000104	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—APOE—pancreatic cancer	3.64e-06	0.000104	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTEN—pancreatic cancer	3.57e-06	0.000102	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PPARG—pancreatic cancer	3.55e-06	0.000101	CbGpPWpGaD
Propofol—ALB—Metabolism—PPARG—pancreatic cancer	3.53e-06	0.000101	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	3.53e-06	0.000101	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—TYMS—pancreatic cancer	3.49e-06	9.93e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CD44—pancreatic cancer	3.47e-06	9.89e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.45e-06	9.81e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—AKT1—pancreatic cancer	3.45e-06	9.81e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AKT1—pancreatic cancer	3.38e-06	9.61e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—APOE—pancreatic cancer	3.35e-06	9.54e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	3.33e-06	9.49e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GCG—pancreatic cancer	3.33e-06	9.48e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—APOE—pancreatic cancer	3.32e-06	9.45e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTGS2—pancreatic cancer	3.3e-06	9.4e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.29e-06	9.36e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	3.27e-06	9.3e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	3.27e-06	9.3e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	3.26e-06	9.29e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.24e-06	9.22e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTGS2—pancreatic cancer	3.23e-06	9.21e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CD—pancreatic cancer	3.22e-06	9.16e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.17e-06	9.03e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.14e-06	8.95e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—STK11—pancreatic cancer	3.13e-06	8.91e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	3.08e-06	8.76e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTGS2—pancreatic cancer	3.05e-06	8.68e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	3.05e-06	8.67e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.02e-06	8.61e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3e-06	8.53e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.92e-06	8.31e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.89e-06	8.23e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.89e-06	8.23e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTEN—pancreatic cancer	2.88e-06	8.2e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—APOE—pancreatic cancer	2.84e-06	8.08e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.82e-06	8.03e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTEN—pancreatic cancer	2.82e-06	8.03e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CB—pancreatic cancer	2.81e-06	7.99e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.8e-06	7.96e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS2—pancreatic cancer	2.78e-06	7.91e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.69e-06	7.67e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.69e-06	7.65e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AKT1—pancreatic cancer	2.67e-06	7.6e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AKT1—pancreatic cancer	2.67e-06	7.6e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTEN—pancreatic cancer	2.66e-06	7.57e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.66e-06	7.57e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.63e-06	7.5e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.56e-06	7.29e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.52e-06	7.17e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	2.52e-06	7.17e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.5e-06	7.1e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AKT1—pancreatic cancer	2.49e-06	7.08e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.47e-06	7.04e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.44e-06	6.94e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTEN—pancreatic cancer	2.42e-06	6.9e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.32e-06	6.59e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.3e-06	6.54e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.29e-06	6.53e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.28e-06	6.48e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.25e-06	6.41e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—APOE—pancreatic cancer	2.19e-06	6.23e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.18e-06	6.2e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKT1—pancreatic cancer	2.06e-06	5.86e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.03e-06	5.78e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTEN—pancreatic cancer	2e-06	5.7e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.99e-06	5.66e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.98e-06	5.65e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.98e-06	5.63e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.96e-06	5.59e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.94e-06	5.54e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.91e-06	5.43e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	1.88e-06	5.34e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.74e-06	4.95e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.72e-06	4.9e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CA—pancreatic cancer	1.71e-06	4.87e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.7e-06	4.83e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.66e-06	4.72e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.63e-06	4.63e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.54e-06	4.37e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.53e-06	4.36e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.51e-06	4.31e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.5e-06	4.27e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.41e-06	4.02e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.4e-06	4e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.4e-06	3.99e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—AKT1—pancreatic cancer	1.4e-06	3.98e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.31e-06	3.73e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.25e-06	3.57e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.2e-06	3.41e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.15e-06	3.28e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.14e-06	3.26e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKT1—pancreatic cancer	9.77e-07	2.78e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	9.23e-07	2.63e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKT1—pancreatic cancer	7.54e-07	2.15e-05	CbGpPWpGaD
